The patent covers OmnySense’s revolutionary method of performing a full 3/6-Lead ECG each time the patient “takes his temperature” This breakthrough technology coupled with automatic assesment ...
Apple may be moving towards commoditizing the on-the-wrist ECG, but other companies in the space aren’t resting on their laurels. AliveCor, which has offered an smartphone-connected ECG since 2012 and ...
WearLinq, a leading provider of wearable health monitoring and diagnosis solutions, today announced the acquisition of AMI Cardiac Monitoring, LLC, an established independent diagnostic testing ...
Investing.com -- HeartBeam Inc (NASDAQ:BEAT) stock surged 52.6% in premarket trading Wednesday after the medical technology company announced it received FDA 510 (k) clearance for its 12-lead ...
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment ...
TipRanks on MSN
HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal
Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming ...
All Penny Stocks (English) on MSN
Credit-Card Sized Device Wins FDA Clearance for At-Home Heart Monitoring
The FDA clearance unlocks multiple growth initiatives for HeartBeam. The company plans a limited commercial launch in Q1 2026 ...
TipRanks on MSN
TrivarX achieves breakthrough in veteran mental health diagnostics with single-lead ECG success
An update from TrivarX Limited ( ($AU:TRI) ) is now available. TrivarX Limited reported positive results from a clinical trial evaluating its ...
HeartBeam BEAT recently secured FDA 510(k) clearance for its first-of-its-kind, cable-free synthesized 12-lead ECG technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback